독립된 질환군으로서의 C1q 신병증
C1q Nephropathy: A Distinct Pathologic Entity
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background : C1q nephropathy (C1qN) is a controversial diagnostic entity defined by Jennette and Hipp in 1985. The prevalence is very low and a few large scale studies have been reported. Application of the criteria for clinical diagnostics of C1qN may cause confusion with other glomerulonephropathies, such as minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS). In order to clarify the confusion with glomerulonephropathies, we did this study to identify the clinicopathological characteristics and the exact disease entity of C1qN. Methods : A total of 5,258 kidney biopsies at Kangnam St Mary’s Hospital were reviewed. Twenty three cases (0.44%) met the criteria of C1qN. Twenty eight cases showing dominant C1q deposits without electron dense depostis (EDD) grouped as C1q+EDD-, and previously diagnosed typical cases of MCD and FSGS were selected for this study. Four groups were compared to each other with regard to the clinical and pathological aspects of the disease. Results : C1qN patients had an average age of 30.4 years. Eighteen were males and 5 were females. Eighty seven percent had proteinuria and 18% had hematuria. By electron microscopy analysis, 100% had mesangial EDD and 47.8% showed foot process effacement. C1qN had some significant differences compared with C1q+EDD-, MCD and FSGS. Conclusions : C1qN is clinically and morphologically different from MCD and FSGS. However, additional long term studies are needed to fully define C1qN from other glomerulonephritis with C1q deposits.
Abstract
Background : C1q nephropathy (C1qN) is a controversial diagnostic entity defined by Jennette and Hipp in 1985. The prevalence is very low and a few large scale studies have been reported. Application of the criteria for clinical diagnostics of C1qN may cause confusion with other glomerulonephropathies, such as minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS). In order to clarify the confusion with glomerulonephropathies, we did this study to identify the clinicopathological characteristics and the exact disease entity of C1qN. Methods : A total of 5,258 kidney biopsies at Kangnam St Mary’s Hospital were reviewed. Twenty three cases (0.44%) met the criteria of C1qN. Twenty eight cases showing dominant C1q deposits without electron dense depostis (EDD) grouped as C1q+EDD-, and previously diagnosed typical cases of MCD and FSGS were selected for this study. Four groups were compared to each other with regard to the clinical and pathological aspects of the disease. Results : C1qN patients had an average age of 30.4 years. Eighteen were males and 5 were females. Eighty seven percent had proteinuria and 18% had hematuria. By electron microscopy analysis, 100% had mesangial EDD and 47.8% showed foot process effacement. C1qN had some significant differences compared with C1q+EDD-, MCD and FSGS. Conclusions : C1qN is clinically and morphologically different from MCD and FSGS. However, additional long term studies are needed to fully define C1qN from other glomerulonephritis with C1q deposits.
참고문헌 (17)
- Jennette JC, "Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens", Am J Clin Pathol, 83, pp.415~420 (1985)
- Jennette JC, "C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome", Am J Clin Kidney Disease, 6, pp.103~110 (1985)
- Roberti I, "A single-center study of C1q nephropathy in children", Pediatr Nephrol, 24, pp.77~82 (2009)
- Vizjak A, "Pathology, clinical presentations and outcomes of C1q nephropathy", J Am Soc Nephrol, 19, pp.2237~2244 (2008)
- Wong CS, "C1q nephropathy and minimal change nephritic syndrome", Pediatr Nephrol, 24, pp.761~767 (2009)
- Markowitz GS, "C1q nephropathy:a variant of focal segmental glomerulosclerosis", Kidney Int, 64, pp.1232~1240 (2003)
- Fukuma Y, "Clinicopathologic correlation of C1q nephropathy in children", Am J Kidney Dis, 47, pp.412~418 (2006)
- Sharman A, "Distinguishing C1q nephropathy from lupus nephritis", Nephrol Dial Transplant, 19, pp.1420~1426 (2004)
- Kim HC, "C1q nephropathy in minimal change nephrotic syndrome: sign of delayed response to steroid therapy?", Korean J Nephrol, 13, pp.841~846 (1994)
- Lee JW, "A case of C1q nephropathy in steroid dependent nephrotic syndrome", J Korean Soc Pediatr Nephrol, 5, pp.206~209 (2001)
- 안형수, "무증상 혈뇨로 발현된 C1q 매개성 신염 1예", The Korean Journal of Nephrology, 24(6), pp.975~979 (2005), 대한신장학회
- In Seok Lim, "Proteinuria in a Boy with Infectious Mononucleosis, C1q Nephropathy,and Dent’s Disease", Journal of Korean Medical Science, 22(5), pp.928~931 (2007), 대한의학회
- Potlukova E, "Complement C1q and anti-C1q antibodies in theory and in clinical practice", Scand J Immunol, 67, pp.4234~4230 (2008)
- Lau KK, "C1q nephropathy:features at presentation and outcome", Pediatr Nephrol, 20, pp.744~749 (2005)
- Iskandar SS, "C1q nephropathy: a pediatric clinicopathologic s", Am J Kidney Dis, 18, pp.459~465 (1991)
- Hisano S, "Clinicopathologic correlation and outcome of C1q nephropathy", Clin J Am Soc Nephrol, 3, pp.1637~1643 (2008)
- Srivastava T, "C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis", Pediatr Nephrol, 14, pp.976~979 (2000)